Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
International Journal of Molecular Sciences|August 10, 2024
Crosstalk among Alternative Polyadenylation, Genetic Variants and Ubiquitin Modification Contribute to Lung Adenocarcinoma RiskYutong Wu, Yanqiong Yuan, Huiwen Xu, et al.Cell Communication and Signaling : CCS|June 3, 2024
NEDD4L mediates ITGB4 ubiquitination and degradation to suppress esophageal carcinoma progressionYijun Shi, Na Fang, Yutong Wu, et al.Theranostics|July 30, 2020
JP1 suppresses proliferation and metastasis of melanoma through MEK1/2 mediated NEDD4L-SP1-Integrin αvβ3 signalingJiahua Cui, Chuanjun Shu, Jin Xu, et al.International Journal of Surgery (London, England)|November 28, 2023
Identification of the consistently differential expressed hub mRNAs and proteins in lung adenocarcinoma and construction of the prognostic signature: a multidimensional analysisYiran Liu, Zhenyu Li, Qianyao Meng, et al.Communications Biology|July 13, 2024
Integrating apaQTL and eQTL analysis identifies a potential causal variant associated with lung adenocarcinoma risk in the Chinese populationHuiwen Xu, Yutong Wu, Qiong Chen, et al.Nature Communications|January 13, 2025
Increased SOAT2 expression in aged regulatory T cells is associated with altered cholesterol metabolism and reduced anti-tumor immunityMingjiong Zhang, Jiahua Cui, Haoyan Chen, et al.Acta Pharmaceutica Sinica. B|October 24, 2025
Divergent activation patterns of BRS3 revealed by two Chinese herb-derived agonistsJie Li, Changyao Li, Qingtong Zhou, et al.Analytical Chemistry|May 4, 2024
High-Sensitivity Differential Helmholtz Photoacoustic System Combined with the Herriott Multipass Cell and Its Application in Seed RespirationGuqing Guo, Lin Li, Yueting Zhou, et al.Acta Biomaterialia|February 8, 2024
A pH-responsive cetuximab-conjugated DMAKO-20 nano-delivery system for overcoming K-ras mutations and drug resistance in colorectal carcinomaHuiling Song, Haosheng Li, Xiaonan Shen, et al.International Journal of Molecular Sciences|November 11, 2022
Characterization of a Potent, Selective, and Safe Inhibitor, Ac15(Az8)2, in Reversing Multidrug Resistance Mediated by Breast Cancer Resistance Protein (BCRP/ABCG2)Tsz Cheung Chong, Iris L K Wong, Jiahua Cui, et al.Pageof 7